These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12794866)

  • 21. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
    Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J
    J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary chemistry: getting there from here.
    Joyce GF
    Science; 1997 Jun; 276(5319):1658-9. PubMed ID: 9206829
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B; Stetefeld J
    Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making enzymes.
    Lerner RA; Barbas CF; Janda KD
    Harvey Lect; 1996-1997; 92():1-40. PubMed ID: 15372741
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structural and functional basis of antibody catalysis.
    Wade H; Scanlan TS
    Annu Rev Biophys Biomol Struct; 1997; 26():461-93. PubMed ID: 9241427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody catalysis: biochemistry, immunology, pathology.
    Gabibov A
    Immunol Lett; 2006 Feb; 103(1):1-2. PubMed ID: 16338008
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From molecular diversity to catalysis: lessons from the immune system.
    Schultz PG; Lerner RA
    Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a high-throughput screen for protein catalysts: application to the directed evolution of antibody aldolases.
    Gildersleeve J; Varvak A; Atwell S; Evans D; Schultz PG
    Angew Chem Int Ed Engl; 2003 Dec; 42(48):5971-3. PubMed ID: 14679545
    [No Abstract]   [Full Text] [Related]  

  • 38. An unprecedented catalytic motif revealed in the model structure of amide hydrolyzing antibody 312d6.
    Benedetti F; Berti F; Brady K; Colombatti A; Pauletto A; Pucillo C; Thomas NR
    Chembiochem; 2004 Jan; 5(1):129-31. PubMed ID: 14695523
    [No Abstract]   [Full Text] [Related]  

  • 39. Selection and characterization of lipase abzyme from phage displayed antibody libraries.
    Leong MK; Chen C; Shar KC; Shiuan D
    Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.